For: | Witthoeft T, Fuchs M, Ludwig D. Recent IV-drug users with chronic hepatitis C can be efficiently treated with daily high dose induction therapy using consensus interferon: An open-label pilot study. World J Gastroenterol 2007; 13(4): 579-584 [PMID: 17278224 DOI: 10.3748/wjg.v13.i4.579] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v13/i4/579.htm |
Number | Citing Articles |
1 |
April M. Young, Richard A. Crosby, Carrie B. Oser, Carl G. Leukefeld, Dustin B. Stephens, Jennifer R. Havens. Hepatitis C viremia and genotype distribution among a sample of nonmedical prescription drug users exposed to HCV in rural Appalachia. Journal of Medical Virology 2012; 84(9): 1376 doi: 10.1002/jmv.23252
|
2 |
Kenneth Freedman, Jay Nathanson. Interferon-based hepatitis C treatment in patients with pre-existing severe mental illness and substance use disorders. Expert Review of Anti-infective Therapy 2009; 7(3): 363 doi: 10.1586/eri.09.1
|
3 |
Andrea K Erickson, Scott Seiwert, Michael Gale. Antiviral Potency Analysis and Functional Comparison of Consensus Interferon, Interferon-α2a and Pegylated Interferon-α2b against Hepatitis C virus Infection. Antiviral Therapy 2008; 13(7): 851 doi: 10.1177/135965350801300706
|
4 |
Karin Neukam, Juan Macías, José A Mira, Juan A Pineda. A review of current anti-HCV treatment regimens and possible future strategies. Expert Opinion on Pharmacotherapy 2009; 10(3): 417 doi: 10.1517/14656560802694481
|
5 |
Brian B. Gowen, Min-Hui Wong, Kie-Hoon Jung, Lawrence M. Blatt, Robert W. Sidwell. Prophylactic and therapeutic intervention of Punta Toro virus (Phlebovirus, Bunyaviridae) infection in hamsters with interferon alfacon-1. Antiviral Research 2008; 77(3): 215 doi: 10.1016/j.antiviral.2007.12.002
|